- FOLFOX/FOLFIRI–Bevacizumab for Unresectable Colorectal Liver Metastases
- Toripalimab for Extensive-Stage Small Cell Lung Cancer
- Advancing Global Pharmacoequity in Oncology
- Concerns Regarding the Utility of High-Risk Pancreatic Cancer Surveillance
- Concerns Regarding Sample Size and Credibility of Progression-Free Survival—Reply
- Financial Toxicity Among Asian American Cancer Survivors
- First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases
- Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
- JAMA Oncology
- Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
- Change of Article Status to Open Access
- More on Waterpipe Tobacco Smoking and Cancer Mortality Content —Reply
- Errors in Figures 2 and 3
- Concerns Regarding Sample Size and Credibility of Progression-Free Survival
- More on Waterpipe Tobacco Smoking and Cancer Mortality Content
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
